Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application DOI Creative Commons
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan

и другие.

Vaccines, Год журнала: 2024, Номер 12(11), С. 1282 - 1282

Опубликована: Ноя. 15, 2024

Milk-derived extracellular vesicles (mEVs) are emerging as promising therapeutic candidates due to their unique properties and versatile functions. These play a crucial role in immunomodulation by influencing macrophage differentiation cytokine production, potentially aiding the treatment of conditions such bone loss, fibrosis, cancer. mEVs also have capacity modulate gut microbiota composition, which may alleviate symptoms inflammatory bowel diseases promote intestinal barrier integrity. Their potential drug delivery vehicles is significant, enhancing stability, solubility, bioavailability anticancer agents while supporting wound healing reducing inflammation. Additionally, bovine exhibit anti-aging protect skin cells from UV damage. As vaccine platforms, offer advantages including biocompatibility, antigen protection, ability elicit robust immune responses through targeted specific cells. Despite these applications, challenges persist, complex roles cancer, effective loading, regulatory hurdles, need for standardized production methods. Achieving high targeting specificity understanding long-term effects mEV-based therapies essential clinical translation. Ongoing research aims optimize mEV methods, enhance capabilities, conduct rigorous preclinical studies. By addressing challenges, hold revolutionize development delivery, ultimately improving outcomes across various medical fields.

Язык: Английский

Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia DOI Creative Commons

Vijay Murali Ravi Mythili,

Ramya Lakshmi Rajendran, Arun Renganathan

и другие.

Bioengineering, Год журнала: 2025, Номер 12(1), С. 92 - 92

Опубликована: Янв. 20, 2025

Critical limb ischemia (CLI) poses a substantial and intricate challenge in vascular medicine, necessitating the development of innovative therapeutic strategies to address its multifaceted pathophysiology. Conventional revascularization approaches often fail adequately complexity CLI, identification alternative methodologies. This review explores uncharted territory beyond traditional therapies, focusing on potential two distinct yet interrelated entities: cell-derived extracellular vesicles (EVs) artificial nanovesicles. Cell-derived EVs are small membranous structures naturally released by cells, nanovesicles artificially engineered nanosized vesicles. Both these represent promising avenues for intervention. They act as carriers bioactive cargo, including proteins, nucleic acids, lipids, that can modulate cellular responses associated with ischemic tissue repair angiogenesis. also assesses evolving landscape CLI through unique perspective The spans spectrum from early preclinical investigations latest translational advancements, providing comprehensive overview current state research this emerging field. These groundbreaking vesicle therapies hold immense revolutionizing treatment paradigms.

Язык: Английский

Процитировано

2

Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases DOI Creative Commons

Valentina Arrè,

Rita Mastrogiacomo, Francesco Balestra

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(4), С. 567 - 567

Опубликована: Апрель 21, 2024

Extracellular vesicles (EVs), acting as inherent nanocarriers adept at transporting a range of different biological molecules such proteins, lipids, and genetic material, exhibit diverse functions within the gastroenteric tract. In states normal health, they participate in upkeep systemic organ homeostasis. Conversely, pathological conditions, significantly contribute to pathogenesis gastrointestinal diseases (GIDs). Isolating EVs from patients' biofluids facilitates discovery new biomarkers that have potential offer rapid, cost-effective, non-invasive method for diagnosing prognosing specific GIDs. Furthermore, demonstrate considerable therapeutic naturally targeted physiological carriers intercellular delivery cargo or nanoscale tools engineered specifically regulate physio-pathological conditions disease progression. Their attributes including safety, high permeability, stability, biocompatibility, low immunogenicity, homing/tropism capabilities their promising clinical applications. This review will delve into various examples serving context GIDs, highlighting both functional structural conditions. The versatile advantageous properties position them candidates innovative strategies advancing personalized medicine approaches tailored tract, addressing

Язык: Английский

Процитировано

5

Enhanced brain delivery and antiproliferative activity of resveratrol using milk-derived exosomes DOI Creative Commons
María Ángeles Ávila‐Gálvez,

Beatriz Garay-Mayol,

Juan Antonio Giménez‐Bastida

и другие.

Journal of Agriculture and Food Research, Год журнала: 2024, Номер 18, С. 101370 - 101370

Опубликована: Авг. 25, 2024

The polyphenol resveratrol (RSV) undergoes extensive phase II metabolism, which limits its bioavailability and bioactivity, including anticancer effects. Growing preclinical evidence reinforces milk-derived exosomes (EXOs) as promising nanocarrier drugs bioactives delivery systems. Herein, to overcome the mentioned RSV's drawbacks, EXOs were loaded with RSV (EXO-RSV) evaluate brain in Sprague-Dawley rats vitro antiproliferative effects against human neuroblastoma SH-SY5Y glioblastoma U-87MG cancer cells compared non-encapsulated RSV. Pharmacokinetic analyses perfused brains showed detection only after EXO-RSV administration, not administration. Encapsulation also resulted lower concentrations of II-derived metabolites circulation. Additionally, blood-brain barrier (BBB) transport assays using microvascular endothelial (HBMECs) corroborated that encapsulation enhanced efficiency protected it from cellular metabolism. In silico phase-II conjugates, primarily 3-glucuronide, capacity than cross BBB. Finally, (47−750 nM) an increased dose-dependent efficacy on both cell lines (10 μM), was ineffective 72 h treatment. Our findings suggest protect metabolism enhance activity.

Язык: Английский

Процитировано

4

Encapsulation of synthesized purpurin-18-N-aminoimide methyl ester in lipid nanovesicles for use as agents in photodynamic cancer therapy DOI
Sooho Yeo, Huiqiang Wu,

Young Kyu Song

и другие.

Journal of Pharmaceutical Sciences, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Unlocking Exosome Therapeutics: The Critical Role of Pharmacokinetics in Clinical Applications DOI
Krishna Yadav, Kantrol Kumar Sahu,

Sucheta

и другие.

Tissue and Cell, Год журнала: 2025, Номер 93, С. 102749 - 102749

Опубликована: Янв. 23, 2025

Язык: Английский

Процитировано

0

Advances in Oral Biomacromolecule Therapies for Metabolic Diseases DOI Creative Commons
Qiuxia Jiao, Yuan Huang, Jinhan He

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(2), С. 238 - 238

Опубликована: Фев. 12, 2025

Metabolic diseases like obesity and diabetes are on the rise, therapies with biomacromolecules (such as proteins, peptides, antibodies, oligonucleotides) play a crucial role in their treatment. However, these drugs traditionally injected. For patients chronic (e.g., metabolic diseases), long-term injections accompanied by inconvenience low compliance. Oral administration is preferred, but delivery of challenging due to gastrointestinal barriers. In this article, we introduce available biomacromolecule for treatment diseases. The barriers oral drug strategies overcome also explored. We then discuss alleviating defects, including glucose metabolism, lipid energy such insulin, glucagon-like peptide-1 receptor agonists, proprotein convertase subtilisin/kexin type 9 inhibitors, fibroblast growth factor 21 analogues, peptide YY analogues.

Язык: Английский

Процитировано

0

Human milk-derived extracellular vesicle treatment promotes the heat shock response in neonates with perinatal high fat diet exposure. DOI Open Access
J. Storm,

Jueqin Lu,

Mon Francis Obtial

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown

Опубликована: Фев. 21, 2025

Abstract Maternal consumption of a high-fat diet (mHFD) during perinatal life (the collective prenatal and postnatal periods) influences neonatal development, initiates hypothalamic-pituitary-adrenal (HPA) axis activation, impacts the long-term physiological metabolic health offspring. Milk-derived extracellular vesicles (MEVs) are lipid-coated nanovesicles found in mammalian milk that survive intestinal degradation cross complex biological barriers, including blood-brain barrier. MEVs have known cytoprotective activity peripheral organs; however, their pro-survival functions response to chronic pro-inflammation stemming from early nutrient stress remain unknown brain. Further, sex differences resulting MEV treatment require investigation, as male female neonates illicit variable responses stress. We investigated whether promote heat shock (HSR), principal mechanism responsible for refolding or degrading misfolded protein aggregates through action (HSP) chaperones. interaction between HSR liver, hypothalamus, prefrontal cortex rats exposed mHFD within hyporesponsive period at day 11. robustly modulated with largest recorded cortex. Specifically, cortex, led an upregulation main transcription factor (HSF1), while downregulating negative regulators HSF1 (Hsp70 Hsp90). These results suggest may influence outcomes by activating HSF1-mediated specific manner mHFD.

Язык: Английский

Процитировано

0

Montbretia flowers as a source of bioactive crocins: biotechnology tools and delivery systems DOI Creative Commons
Lucía Morote, Cristián Martinez Fajardo, María Mondejar‐López

и другие.

Biotechnology Reports, Год журнала: 2025, Номер 46, С. e00891 - e00891

Опубликована: Март 30, 2025

Crocins are potent antioxidants with significant therapeutic potential, exhibiting anti-inflammatory, anticancer, and antidepressant properties. The ornamental plant Crocos-mia x crocosmiiflora is widely cultivated for its aromatic vibrant flowers. In this study, we identified unique crocins as the primary pigments responsible flower's coloration. These metabolites predominantly consist of molecules eight glucose units, followed by containing six seven units. To elucidate mo-lecular mechanisms underlying crocin biosynthesis in C. crocosmiiflora, tran-scriptomic analysis was performed to identify key carotenoid cleavage dioxygenase (CCD) genes. Using Crocus sativus CsCCD2L gene a bait, CCD transcript from transcriptome data. Phylogenetic revealed that belongs CCD2 subfamily, it designated CroCCD2. Functional characterization CroCCD2 carried out using bacterial expression systems Nicotiana benthamiana plants virus-mediated system. experiments demonstrated efficiently converts precursor zeaxanthin into crocetin, intermediate biosynthesis. Furthermore, investigated bioactivity discovered their anti-inflammatory effects depend on vehiculation within exosomes or liposomes. This suggests transport mechanism critical biological activity crocins. Our findings highlight specialization subfamilies monocots dicots provide evidence exosome-transported study establishes foundation further research metabolic network could be introduced other crop produce these bioactive apocarotenoids.

Язык: Английский

Процитировано

0

Emerging Roles of Plant‐Derived Extracellular Vesicles in Biotherapeutics: Advances, Applications, and Future Perspectives DOI
Cheng Li,

Aoqiong Zeng,

Li Li

и другие.

Advanced Biology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 8, 2025

Abstract Extracellular vesicles (EVs) are nanoscale luminal vesicles, which play an important role in intercellular communication through surface signaling and molecular cargo delivery (proteins, lipids, nucleic acids, etc.). Recently, plant‐derived extracellular (PDVs) containing multiple biological activities have received increasing attention due to their better biocompatibility lower cytotoxicity healthy tissues. In the biomedical field, PDVs employed as vehicles, enabling diverse functionalities engineering modification techniques. Nonetheless, there certain issues with study of PDVs, such lack standardization identification isolation criteria. This review provides a quick overview biogenesis, physicochemical properties, techniques, applications current studies, while critically analyzing challenges opportunities. paper is expected provide some theoretical guidance for development further applications.

Язык: Английский

Процитировано

0

Exosome-like nanoparticles from Arbutus unedo L mitigate LPS-induced inflammation via JAK-STAT inactivation DOI
Cristián Martinez Fajardo,

Lucía Morote,

Elena Moreno Giménez

и другие.

Food & Function, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Exosomes have garnered attention as a potential cell-free therapy for inflammatory diseases due to their immunomodulatory and anti-inflammatory properties.

Язык: Английский

Процитировано

2